These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 18594872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B, Taieb F, Conti F, Abbas H, Seydi I, Harcouet L, Dauphin A, Calmus Y, Tod M.
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [Abstract] [Full Text] [Related]

  • 3. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
    Kunicki PK, Pawiński T, Boczek A, Waś J, Bodnar-Broniarczyk M.
    Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay.
    Beal JL, Jones CE, Taylor PJ, Tett SE.
    Ther Drug Monit; 1998 Dec; 20(6):685-90. PubMed ID: 9853989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay.
    Hosotsubo H, Takahara S, Imamura R, Kyakuno M, Tanaka T, Yazawa K, Hanafusa T, Matsumiya K, Nonomura N, Okuyama A, Sugimoto H.
    Ther Drug Monit; 2001 Dec; 23(6):669-74. PubMed ID: 11802102
    [Abstract] [Full Text] [Related]

  • 8. Correlation between enzyme multiplied immunoassay technique and high-performance liquid chromatography in the quantification of voriconazole in a paediatric population.
    Li X, Li W, Li M, Zhang Z, Liu S, Chen Z.
    Scand J Clin Lab Invest; 2021 Apr; 81(2):121-126. PubMed ID: 33426972
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
    Prémaud A, Rousseau A, Le Meur Y, Lachâtre G, Marquet P.
    Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 13. Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics.
    Parant F, Rivet C, Boulieu R, Gagnieu MC, Dumortier J, Boillot O, Lachaux A.
    Ther Drug Monit; 2009 Dec; 31(6):727-33. PubMed ID: 19881404
    [Abstract] [Full Text] [Related]

  • 14. Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection?
    De Nicolò A, Ianniello A, Benagli C, Della Bruna R, Keller F, Antonucci M, D'Avolio A, Cantù M.
    J Pharm Biomed Anal; 2020 Aug 05; 187():113337. PubMed ID: 32442868
    [Abstract] [Full Text] [Related]

  • 15. Comparison of a Point-of-Care Testing with Enzyme-Multiplied Immunoassay Technique and Liquid Chromatography Combined With Tandem Mass Spectrometry Methods for Therapeutic Drug Monitoring of Mycophenolic Acid: A Preliminary Study.
    Zhou H, Xiang H, Cai J, Wang Y, Zhang M, Han Y, Zhang Y.
    Ther Drug Monit; 2021 Oct 01; 43(5):630-636. PubMed ID: 33394991
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
    Aw MM, Brown NW, Itsuka T, Gonde CE, Adams JE, Heaton ND, Tredger JM, Mieli-Vergani G, Dhawan A.
    Liver Transpl; 2003 Apr 01; 9(4):383-8. PubMed ID: 12682891
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolic acid monitoring in HTX patients: a preliminary report.
    Müller MM, Vogl M, Griesmacher A.
    Therapie; 1997 Apr 01; 52(4):341-4. PubMed ID: 9437889
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit.
    Shipkova M, Schütz E, Armstrong VW, Niedmann PD, Oellerich M, Wieland E.
    Clin Chem; 2000 Mar 01; 46(3):365-72. PubMed ID: 10702523
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD.
    Liver Transpl; 2007 Nov 01; 13(11):1570-5. PubMed ID: 17969194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.